The Kanabo share price: is now the time to buy?

The Kanabo share price surged by more than 500% after its IPO! Today it’s much lower. Could this be a buying opportunity? Zaven Boyrazian investigates.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Kanabo Group (LSE:KNB) share price exploded in its first week of trading last month, increasing from its issue price of 6.5p to a high of just over 40p. That’s more than a 500% rise in a matter of days!

Since then, the Kanabo share price has fallen down to 23p. But is this a buying opportunity for my growth portfolio? Let’s take a look.

What does Kanabo Group do?

Kanabo develops and manufactures CBD-based products and inhalers. The business has been around for a couple of years but has only recently begun selling anything.

It is currently in the middle of a three-month pilot scheme designed to measure several key performance indicators concerning the sale of its products. Specifically testing general demand, supply chain effectiveness, and quality controls.

But this is not the long-term strategy of the business. Using the income generated from selling retail products, Kanabo intends to produce a range of unlicensed medical cannabis oils to be used with its vaporisation devices.

If successful, this could form a viable razor-and-blades business model that could cause the Kanabo share price to rise even higher. But there are plenty of risks to consider.

The risks of investing early

Just like many start-ups, Kanabo has yet to create any proven products or establish a well-known brand. The results from its pilot scheme have revealed some level of customer retention, with around 40% coming back to buy more. While this is undoubtedly a promising start, I believe it needs to be much higher. I’ll be closely watching whether management can boost this metric over time.

This is especially important since the medical cannabis oil products that the company intends to make are going to be unlicensed. Why does that matter? An unlicensed medication doesn’t require extensive clinical trials nor regulatory approval before becoming publically available. This significantly reduces development costs. But consequently, it also means that Kanabo’s oils will never be prescribed by the NHS, as there are already existing licensed products available that fulfil the same role.

Naturally, this creates a significant barrier to entry for Kanabo’s future medical products. And so, the company will have to rely on the reputation of its existing brands to drive sales. Given it has yet to build any substantial reputation, this may be tough.

The Kanabo share price has plenty of risks ahead

Can the Kanabo share price climb higher?

The medical cannabis industry is growing rapidly by almost 18% a year. And as more countries legalise medical marijuana, this growth may accelerate. This ultimately creates an excellent environment for Kanabo to thrive in. However, let’s not forget there are plenty of other companies trying to do the same thing.

Personally, it’s too soon for me to add Kanabo to my portfolio, even at its current share price. But I’ll definitely be keeping an eye on it.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zaven Boyrazian does not own shares in Kanabo Group. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »